Prosecution Insights
Last updated: October 01, 2026
Application No. 18/717,747

HERBICIDAL ACTIVITY OF ALKYL PHOSPHINATES

Non-Final OA §101§112
Filed
Jun 07, 2024
Priority
Dec 10, 2021 — EU 21213751.7 +1 more
Examiner
PAK, JOHN D
Art Unit
1699
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
BASF SE
OA Round
1 (Non-Final)
52%
Grant Probability
Moderate
1-2
OA Rounds
9m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
530 granted / 1012 resolved
-7.6% vs TC avg
Strong +38% interview lift
Without
With
+37.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
38 currently pending
Career history
1045
Total Applications
across all art units

Statute-Specific Performance

§101
3.2%
-36.8% vs TC avg
§103
42.1%
+2.1% vs TC avg
§102
13.3%
-26.7% vs TC avg
§112
29.3%
-10.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1012 resolved cases

Office Action

§101 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-15 are pending in this application. Applicant’s election of the invention of Group IV, claims 7-14, in the reply filed on 6/23/2026 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Claims 1-6 and 15 are withdrawn from further consideration as being directed to non-elected subject matter. Claims 7-14 will presently be examined. 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 7-12 are rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The claims do not fall within at least one of the four categories of patent eligible subject matter because “Use of” a substance as recited in claims 7-12 does not fall within at least one of the categories of patent eligible subject matter recited in 35 U.S.C. 101: process, machine, manufacture, or composition of matter. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 7-12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. “Use of” of a substance as recited in claims 7-12 fails to recite a process step. It is therefore an incomplete process claim if that were the intended category of invention. The claims are indefinite for this reason. Applicant is advised that claims 7-12 cannot be further examined on the merits for the reasons stated above. Claims 13-14 are deemed allowable. The following is an examiner’s statement of reasons for allowance: CN 1130725791 and DE 31420362 are representative of prior art that teaches the hydantoins encompassed by claims 13-14 as intermediate or reactant in the synthesis of glufosinate or herbicides. However, the prior art fails to disclose, suggest, or otherwise render obvious a method for controlling unwanted vegetation which comprises applying a herbicidally effective amount of said hydantoins, i.e., the hydantoins are the active herbicides, not intermediates or reactants. Therefore, the claims are deemed allowable. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Any inquiry concerning this communication or earlier communications from the Examiner should be directed to JOHN PAK whose telephone number is (571)272-0620. The Examiner can normally be reached on Monday to Friday from 8:30 AM to 5 PM. If attempts to reach the Examiner by telephone are unsuccessful, the Examiner's SPE, Fereydoun Sajjadi, can be reached on (571)272-3311. The fax phone number for the organization where this application or proceeding is assigned is (571)273-8300. Information regarding the status of an application may be obtained from Patent Center. Status information for published applications may be obtained from Patent Center. Status information for unpublished applications is available through Patent Center for authorized users only. Should you have questions about access to Patent Center, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at https://www.uspto.gov/patents/uspto-automated- interview-request-air-form. /JOHN PAK/Primary Examiner, Art Unit 1699 1 CN 113072579 was cited as D1 in the Written Opinion of the counterpart International Application. 2 Machine translation is provided herewith.
Read full office action

Prosecution Timeline

Jun 07, 2024
Application Filed
Sep 04, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742211
BUFFER COMPOSITIONS FOR REDUCING AGGREGATION
4y 8m to grant Granted Sep 22, 2026
Patent 12735406
NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUND HAVING AN OXIME GROUP, AGRICULTURAL OR HORTICULTURAL HERBICIDE COMPRISING THE COMPOUND, AND METHOD FOR USING THE COMPOUND OR THE HERBICIDE
3y 4m to grant Granted Sep 15, 2026
Patent 12733644
METHODS FOR CONTROLLING FUSARIUM WILT OF BANANA PLANTS
3y 3m to grant Granted Sep 15, 2026
Patent 12692238
SUBSTITUTED PYRIDAZINONE HERBICIDES
3y 1m to grant Granted Jul 28, 2026
Patent 12685310
Kit for the treatment of seeds
3y 5m to grant Granted Jul 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
52%
Grant Probability
90%
With Interview (+37.7%)
3y 1m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1012 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month